4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-24-000026
Chief Medical Officer acquired 11,366 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2024-06-11 | Option exercise | +5,017 | $0.54 | $2,709 | 83,380 | D: show line 1 in the form |
| Rodman David Malcom Chief Medical Officer | 2024-06-12 | Option exercise | +6,349 | $1.08 | $6,857 | 89,729 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2024-06-11 | Option exercise · Stock Option | −5,017 | 35,121 | D: show line 3 in the form | ||
| Rodman David Malcom Chief Medical Officer | 2024-06-12 | Option exercise · Stock Option | −6,349 | 190,357 | D: show line 4 in the form |
Loading xslF345X05/wk-form4_1718314321.xml…